PeptiDream (OTCMKTS:PPTDF – Get Free Report) is anticipated to issue its results after the market closes on Wednesday, November 11th. Analysts expect PeptiDream to post earnings of ($0.0445) per share and revenue of $32.12 million for the quarter.
PeptiDream Stock Performance
Shares of PeptiDream stock opened at $6.80 on Wednesday. The company’s 50 day moving average price is $6.96 and its two-hundred day moving average price is $7.48. PeptiDream has a fifty-two week low of $5.88 and a fifty-two week high of $12.85.
PeptiDream Company Profile
PeptiDream Inc is a Japanese biopharmaceutical company focused on the discovery and development of peptide-based therapeutics. The company uses its proprietary Peptide Discovery Platform System (PDPS) to identify peptides, including highly selective macrocyclic and other nonstandard peptides, that may be developed into medicines for a range of diseases.
PeptiDream applies its platform to internal drug-development programs and research collaborations with pharmaceutical and biotechnology companies.
Featured Articles
- Five stocks we like better than PeptiDream
- Tower Semiconductor’s Earnings Are Soaring—So Why Is Its Stock Down More Than 50%?
- Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
Receive News & Ratings for PeptiDream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PeptiDream and related companies with MarketBeat.com's FREE daily email newsletter.
